Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126842652 | 12684265 | 2 | F | 2016 | 20160916 | 20160825 | 20160919 | EXP | US-AMGEN-USASP2016108114 | AMGEN | 65.00 | YR | E | F | Y | 0.00000 | 20160919 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126842652 | 12684265 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK, AFTER CHEMO | 125031 | SOLUTION FOR INJECTION | |||||||||
126842652 | 12684265 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK, AFTER CHEMO | A40264-0003046 | 125031 | SOLUTION FOR INJECTION | ||||||||
126842652 | 12684265 | 3 | SS | TAXOTERE | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
126842652 | 12684265 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
126842652 | 12684265 | 5 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
126842652 | 12684265 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126842652 | 12684265 | 1 | Product used for unknown indication |
126842652 | 12684265 | 3 | Breast cancer |
126842652 | 12684265 | 4 | Breast cancer |
126842652 | 12684265 | 5 | Breast cancer |
126842652 | 12684265 | 6 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126842652 | 12684265 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126842652 | 12684265 | Abdominal pain upper | |
126842652 | 12684265 | Alopecia | |
126842652 | 12684265 | Aphonia | |
126842652 | 12684265 | Asthenia | |
126842652 | 12684265 | Bone pain | |
126842652 | 12684265 | Feeling abnormal | |
126842652 | 12684265 | Headache | |
126842652 | 12684265 | Hypophagia | |
126842652 | 12684265 | Insomnia | |
126842652 | 12684265 | Intentional product misuse | |
126842652 | 12684265 | Malaise | |
126842652 | 12684265 | Mobility decreased | |
126842652 | 12684265 | Myalgia | |
126842652 | 12684265 | Nasopharyngitis | |
126842652 | 12684265 | Nausea | |
126842652 | 12684265 | Neuropathy peripheral | |
126842652 | 12684265 | Pain in extremity | |
126842652 | 12684265 | Productive cough | |
126842652 | 12684265 | Pulmonary congestion | |
126842652 | 12684265 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126842652 | 12684265 | 1 | 20160420 | 20160601 | 0 | |
126842652 | 12684265 | 2 | 20160622 | 0 | ||
126842652 | 12684265 | 3 | 20160419 | 0 | ||
126842652 | 12684265 | 4 | 20160419 | 0 | ||
126842652 | 12684265 | 5 | 20160712 | 0 | ||
126842652 | 12684265 | 6 | 20160712 | 0 |